project presentaion bpharm 4 2015

 

 

 Presenter of project Lugano  Mwankemwa     INTRODUCTION

  The availability of ACTs as first line drugs in treating uncomplicated malaria is significant in eradication of the disease.

Results from this study will be useful for planners and government to plan and improve strategies on ensuring that ACTs are available at reasonable   price(subsidized) in community pharmacies

 conclusion

Availability of  ACTs   remained a challenge in the outlets in  Tanzania. First-line therapy the  ACTs(subsidized) were less available , high price   were observed for ALUs(not subsidized) .  other artemisinin derivatives were more available than ALUs and more expensive. Challenges in high price(unsubsidized) and out of stock of ACTs(subsidized) has resulted into use of alternative antimalarial which was removed as first line , Collectively, availability, price and affordability of the drugs affect  policy of uses of ACTs as first line

the results showed that the significant extent of variability in labeling  was observed
qualitative lists of excipients were mostly missing
method of administration, absence of name and adders of manufacturer
ciprofloxacin showed the most variability